Hemodynamics and exercise tolerance during application of transdermal systems with phasic nitroglycerin (NTG) release in comparison to 20 mg isosorbide mononitrate.
Jansen
W
W
Medizinische Klinik I, Städtisches Krankenhaus Leverkusen, Germany.
Hinsche
A
A
Rappert
B
B
Geppert
R
R
Tauchert
M
M
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D015444:Exercise; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage / Q000494:pharmacology*; D010807:Physical Endurance / Q000187:drug effects
D005996:Nitroglycerin; D007548:Isosorbide Dinitrate